Massive Demand – Extended IPO Period
The demand from patient organizations and relatives to get Brighter One™ demonstrated has by far surpassed Brighter’s expectations. Since the company wishes to spread the information about the company and Brighter OneTM as broadly as possibly, the board decided to extend the issuing period until September 26. “The response we have received is fantastic and an extension serves a dual purpose. On the one hand, we get to meet more interested investors, but above all, we get a splendid chance to demonstrate Brighter One for those who will actually use it” says Truls Sjöstedt, CEO.